Boston Scientific Aggregate Notional Principal Outstanding increased by 6.6% to $14.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.8%, from $10.54B to $14.63B. Over 5 years (FY 2020 to FY 2025), Aggregate Notional Principal Outstanding shows an upward trend with a 3.9% CAGR.
aggregate_notional_principal_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.34B | $10.67B | $9.38B | $9.41B | $7.92B | $7.88B | $8.32B | $7.66B | $7.36B | $7.00B | $6.90B | $6.95B | $6.90B | $7.48B | $8.64B | $10.54B | $11.83B | $13.08B | $13.72B | $14.63B |
| QoQ Change | — | -5.9% | -12.1% | +0.3% | -15.9% | -0.5% | +5.6% | -8.0% | -3.9% | -4.9% | -1.5% | +0.8% | -0.8% | +8.4% | +15.6% | +22.0% | +12.2% | +10.6% | +4.9% | +6.6% |
| YoY Change | — | — | — | — | -30.2% | -26.2% | -11.3% | -18.6% | -7.0% | -11.1% | -17.1% | -9.2% | -6.3% | +6.8% | +25.3% | +51.6% | +71.5% | +75.0% | +58.8% | +38.8% |